IFP Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.7K | Buy |
1,770
+1,307
| +282% | +$11.7K | ﹤0.01% | 3084 |
|
|
2026
Q1 | $3.77K | Buy |
463
+102
| +28% | +$925 | ﹤0.01% | 3690 |
|
|
2025
Q4 | $2.43K | Hold |
361
| – | – | ﹤0.01% | 3770 |
|
|
2025
Q3 | $3.13K | Sell |
361
-4,314
| -92% | -$33.6K | ﹤0.01% | 3494 |
|
|
2025
Q2 | $31.1K | Buy |
4,675
+679
| +17% | +$4.5K | ﹤0.01% | 2302 |
|
|
2025
Q1 | $25.6K | Buy |
3,996
+350
| +10% | +$2.89K | ﹤0.01% | 2194 |
|
|
2024
Q4 | $29.6K | Buy |
3,646
+201
| +6% | +$1.94K | ﹤0.01% | 2075 |
|
|
2024
Q3 | $43.5K | Hold |
3,445
| – | – | ﹤0.01% | 1798 |
|
|
2024
Q2 | $43.6K | Buy |
3,445
+400
| +13% | +$4.02K | ﹤0.01% | 1738 |
|
|
2024
Q1 | $14.6K | Hold |
3,045
| – | – | ﹤0.01% | 2109 |
|
|
2023
Q4 | $14.6K | Hold |
3,045
| – | – | ﹤0.01% | 2043 |
|
|
2023
Q3 | $22K | Buy |
3,045
+455
| +18% | +$3.64K | ﹤0.01% | 1893 |
|
|
2023
Q2 | $19.2K | Buy |
2,590
+454
| +21% | +$3.57K | ﹤0.01% | 2022 |
|
|
2023
Q1 | $14K | Sell |
2,136
-4,858
| -69% | -$44.7K | ﹤0.01% | 2158 |
|
|
2022
Q4 | $52K | Buy |
6,994
+5,361
| +328% | +$94.6K | ﹤0.01% | 2221 |
|
|
2022
Q3 | $20K | Buy |
1,633
+1,328
| +435% | +$57.5K | ﹤0.01% | 3086 |
|
|
2022
Q2 | $9K | Hold |
305
| – | – | ﹤0.01% | 3474 |
|
|
2022
Q1 | $9K | Buy |
305
+111
| +57% | +$9.9K | ﹤0.01% | 3474 |
|
|
2021
Q4 | $27K | Sell |
194
-52
| -21% | -$8.94K | ﹤0.01% | 1815 |
|
|
2021
Q3 | $52K | Sell |
246
-74
| -23% | -$16.3K | ﹤0.01% | 1562 |
|
|
2021
Q2 | $69K | Buy |
320
+28
| +10% | +$5.13K | ﹤0.01% | 1390 |
|
|
2021
Q1 | $54K | Sell |
292
-44
| -13% | -$8.77K | ﹤0.01% | 1440 |
|
|
2020
Q4 | $36K | Buy |
336
+95
| +39% | +$10.1K | ﹤0.01% | 1563 |
|
|
2020
Q3 | $26K | Buy |
+241
| New | +$29.4K | ﹤0.01% | 1537 |
|
|
2020
Q2 | – | Sell |
-13
| Closed | -$497 | – | 2880 |
|
|
2020
Q1 | $0 | Buy |
+13
| New | +$110 | ﹤0.01% | 2917 |
|
|
2019
Q1 | – | Sell |
-245
| Closed | -$9K | – | 3066 |
|
|
2018
Q4 | $9K | Sell |
245
-50
| -17% | -$1.94K | ﹤0.01% | 2565 |
|
|
2018
Q3 | $11K | Sell |
295
-34
| -10% | -$957 | ﹤0.01% | 2803 |
|
|
2018
Q2 | $9K | Buy |
329
+105
| +47% | +$3.55K | ﹤0.01% | 2971 |
|
|
2018
Q1 | $6K | Hold |
224
| – | – | ﹤0.01% | 3089 |
|
|
2017
Q4 | $6K | Sell |
224
-524
| -70% | -$12.8K | ﹤0.01% | 3135 |
|
|
2017
Q3 | $17K | Hold |
748
| – | – | ﹤0.01% | 2712 |
|
|
2017
Q2 | $17K | Sell |
748
-1,030
| -58% | -$20.2K | ﹤0.01% | 2679 |
|
|
2017
Q1 | $46K | Sell |
1,778
-67
| -4% | -$1.84K | ﹤0.01% | 1980 |
|
|
2016
Q4 | $46K | Sell |
1,845
-203
| -10% | -$5.92K | ﹤0.01% | 1933 |
|
|
2016
Q3 | $85K | Buy |
2,048
+373
| +22% | +$48.2K | ﹤0.01% | 1467 |
|
|
2016
Q2 | $244K | Buy |
+1,675
| New | +$192K | 0.01% | 877 |
|
|
2016
Q1 | – | Sell |
-1,391
| Closed | -$233K | – | 3059 |
|
|
2015
Q4 | $233K | Buy |
+1,391
| New | +$214K | 0.02% | 774 |
|
Other funds holding NVAX
SCM
S
IFP Advisors's NVAX Position: Q2 2026 in Review
IFP Advisors increased its Novavax (NVAX) stake by 282% in Q2 2026, buying an estimated $11.7K and bringing the position to 1,770 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3084.
IFP Advisors first reported a position in NVAX in Q4 2015 and has held it in 37 quarters since. The position peaked at $244K in Q2 2016. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- IFP Advisors held 1,770 shares of Novavax worth $16.7K as of Q2 2026.
- IFP Advisors bought 1,307 Novavax shares in Q2 2026, an estimated $11.7K.
- Novavax made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3084 holding.
- IFP Advisors first reported a position in Novavax in Q4 2015 and has held it in 37 quarters since.
- IFP Advisors's Novavax position peaked at $244K in Q2 2016.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.